Yes. Under the 2026 iPLEDGE changes, prescribers may allow planned home pregnancy testing during and after isotretinoin treatment for adult acne patients. iPLEDGE is the Food and Drug Administration safety program for isotretinoin, a drug for severe nodular acne.
The update reduces lab burden while keeping strict pregnancy prevention. According to the FDA approval notice reported by Drugs.com, FDA approved the changes on Feb. 9, 2026, with implementation required Aug. 9, 2026.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What changed for pregnancy testing?
- Who can use planned home testing?
- What still needs a clinic or lab visit?
- How does this affect follow-up care?
- What to confirm before your next refill?
What changed for pregnancy testing?
The FDA record removes the requirement that pregnancy tests be performed in a CLIA-certified laboratory. That change opens the door to prescriber-approved home testing during and after treatment.
According to the FDA REMS record, home testing must be paired with measures to minimize falsification of results. Prescribers must still verify and document each negative result.
Who can use planned home testing?
The option applies to patients who can become pregnant and take isotretinoin for severe nodular acne. The prescriber decides whether home testing is appropriate for each patient.
The National Community Pharmacists Association reports in its NCPA summary that these patients need a documented negative test before each 30-day prescription. They must fill that prescription within 7 days of specimen collection.
What still needs a clinic or lab visit?
All pregnancy testing before starting isotretinoin must still occur in a medical setting. That means a prescriber office, clinic, or laboratory, not home.
This first test establishes a reliable baseline before fetal exposure can occur. A home test cannot replace it, even if later tests are done at home.
How does this affect follow-up care?
For adults juggling work and appointments, approved home testing can support telemedicine follow-up and fewer lab visits. The prescriber still sets the test date, reviews the result, and records it in iPLEDGE.
A missed 7-day fill window no longer triggers a 19-day lockout. A repeat pregnancy test can be done immediately without an added waiting period.
What to confirm before your next refill?
Ask whether your prescriber allows home testing for your current cycle. Confirm the approved test type, testing day, and how to submit proof. Bring the unused test to your video visit if asked, and keep the dated result until the prescription is filled.
- Approved brand or test type and where to obtain it
- Exact test date tied to your 30-day prescription window
- How to share the result, such as photo, video visit, or portal upload
- Pharmacy fill deadline within 7 days of specimen collection
- What to do if a test is unclear, missed, or positive
You Might Also Like
- Planned Home Pregnancy Testing Under the 2026 iPLEDGE Changes: What Changed, What Did Not, and What Comes Next for Adult Acne Patients
- Pretreatment Pregnancy Testing Under iPLEDGE in 2026: What Changed, What Did Not, and What Comes Next for Adult Acne Patients
- Pretreatment Pregnancy Testing Under iPLEDGE in 2026: Pharmacy and Prescriber Questions for Adult Acne Patients